NHSN Logo Hemovigilance Module - Monthly Reporting Denominator

Document Id 20202201 (2.16.840.1.113883.3.117.1.1.5.2.1.1.2)
Document Created July 1, 2015
Case Hemovigilance Module - Monthly Reporting Denominator from July 1, 2015 to July 31, 2015
Author aSoftwareID (2.16.840.1.113883.3.117.1.1.5.2.1.1)
Document maintained by 2.16.840.1.114222.4.3.2.11
Encounter Location 2.16.840.1.113883.3.117.1.1.5.1.1
Legal authenticator aLegalAuthenticatorID (2.16.840.1.113883.3.117.1.1.5.1.1.2)
signed date/time: July 1, 2008

Summary Data

Facility: FACWIDEIN Facility-wide Inpatient (FacWIDEIn) Reporting Start: July 1, 2015
No hemovigilance adverse reactions reported this month Yes
No hemovigilance incidents reported this month No


Products Units Transfused Aliquots Transfused Total Discards
Whole Blood Total 100
E0009: 60
E0013: 30
E0014: 10
50
E0009: 50
0
Red Blood Cells Whole Blood Derived Total 12 24 55
Not irradiated or leukocyte reduced 24
E0142: 13
E0146: 11
14
E0150: 14
4
E0154: 2
E0159: 2
Irradiated 0 0 0
Leukocyte Reduced 0 0 0
Irradiated and Leukocyte Reduced 0 0 0
Apheresis Total 0 0 0
Not irradiated or leukocyte reduced 0 0 0
Irradiated 0 0 0
Leukocyte Reduced 0 0 0
Irradiated and Leukocyte Reduced 0 0 0
Platelets Whole Blood Derived TOTAL 0 0
Not irradiated or leukocyte reduced 0 0
Irradiated 0 0
Leukocyte reduced 0 0
Irradiated and leukocyte reduced 0 0
Apheresis TOTAL 0 0 0
Not irradiated or leukocyte reduced 0 0 0
Irradiated 0 0 0
Leukocyte reduced 0 0 0
Irradiated and leukocyte reduced 0 0 0
Plasma (all types) Total Whole blood Derived 0 0 0
Total Apheresis 0 0 0
Cryoprecipitate 0 0
Red Blood Cells Whole Blood Derived TOTAL 30 0 0
S-303-treated 30
NA_RBC_WBD_S-303: 20
0 0
Riboflavin-Treated 0 0 0
Apheresis TOTAL 0 0 0
S-303-treated 0 0 0
Riboflavin-Treated 0 0 0
Platelets Whole Blood Derived Total 0 0
Psoralen-Treated 0 0
Riboflavin-Treated 0 0
Apheresis Total 0 0 0
Psoralen-Treated 0 0 0
Riboflavin-Treated 0 0 0
Plasma (all types) Whole Blood Derived Total 0 0 0
Psoralen-Treated 0 0 0
Riboflavin-Treated 0 0 0
Apheresis Total 0 0 0
Psoralen-Treated 0 0 0
Riboflavin-Treated 0 0 0
Cryoprecipitate TOTAL 0 0
Psoralen-Treated 0 0
Riboflavin-Treated 0 0


Products Units Transfused Aliquots Transfused Total Discards
Platelets Apheresis Psoralen-treated 0 0 0
Psoralen-treated and in Plasma 25
E6020: 20
E8332: 4
E8338: 1
75 75
Psoralen-treated and in Platelet additive solution 75
E5866: 2
E5868: 40
E6640: 8
75 75
Riboflavin-treated 0 0 0
Riboflavin-treated and in Plasma 75 75 75
Riboflavin-treated and in Platelet additive solution 75 75 75


Facility transfuses blood products treated with pathogen reduction technology Yes
Number of patient samples collected for type and screen or crossmatch 25
Total crossmatch procedures 16
Total patients transfused 1024